EFNS task force - therapy of nystagmus and oscillopsia

被引：89

作者：

Straube, A

Leigh, RJ

Bronstein, A

Heide, W

Riordan-Eva, P

Tijssen, CC

Dehaene, I

Straumann, D

机构：

[1] Univ Munich, Dept Neurol, D-80539 Munich, Germany

[2] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA

[3] Univ London Imperial Coll Sci Technol & Med, Acad Dept Neurootol, London, England

[4] Univ Lubeck, Dept Neurol, Lubeck, Germany

[5] Kings Coll Hosp London, Dept Ophthalmol, London, England

[6] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands

[7] Algemeen Hosp, Dept Neurol, Brugge, Belgium

[8] Univ Zurich, Dept Neurol, Zurich, Switzerland

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷 / 02期

关键词：

etiology; nystagmus; ocular motor disorders; opsoclonus; oscillopsia; saceades; treatment;

D O I：

10.1046/j.1468-1331.2003.00754.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

An overview of possible treatment options for oculomotor disorders that prevent clear vision is given. Downbeat nystagmus, upbeat nystagmus, seesaw nystagmus, periodic alternating nystagmus, acquired pendular nystagmus, and saccadic oscillations such as opsoclonus/ocular flutter are discussed. In addition, superior oblique myokymia and vestibular paroxysmia are reviewed. All treatment recommendations available in the literature are classified as class C only. In general, only some of the patients benefit from the treatment.

引用

页码：83 / 89

页数：7

共 74 条

[1]

[Anonymous], 1999, The Neurology of Eye Movements

[2] A double blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus [J].